Venticute in Patients With Pneumonia or Aspiration of Gastric Contents and Intubation/Ventilation/Oxygenation Impairment (BY2001/M1-007)
Summary
The registered summary isn't in our current data snapshot. Read it on the ClinicalTrials.gov record ↗. Why? →
Investigators
The overall officials registered on this study. Names that resolve to a findmyKOL profile link to it; the rest are shown as registered.
- Andreas Günther, MD
University of Giessen
Principal Investigator - Roger G. Spragg, MD
University of California and La Jolla Veterans Affairs Medical Center, San Diego, CA, USA
Principal Investigator - Werner Seeger, MD
Justus-Liebig-Universität, Gießen, Germany
Principal Investigator
A profile link is shown only when the registered name resolves to a person record with a confident, namesake-checked match; ambiguous names stay unlinked.
Sites
92 registered facilities, with the per-site recruitment status where the registry publishes one. ClinicalTrials.gov does not publish per-site enrollment counts.
- Altana Pharma/nycomed
Adelaide SA, Australia
- Altana Pharma/nycomed
Bedford Park, Adelaide S, Australia
- Altana Pharma/nycomed
Clayton, VIC, Australia
- Altana Pharma/nycomed
Fremantle, WA, Australia
- Altana Pharma/nycomed
Heidelberg, Victoria, Australia
- Altana Pharma/nycomed
Kingswood, Sydney, NS, Australia
- Altana Pharma/nycomed
Melbourne VIC, Australia
- Altana Pharma/nycomed
Perth, Western Australi, Australia
- Altana Pharma/nycomed
Southport Gold Coast QL, Australia
- Altana Pharma/nycomed
Victoria, Australia
- Altana Pharma/nycomed
Victoria, Australia
- Altana Pharma/nycomed
Woolloongabba, Queens, Australia
- Altana Pharma/nycomed
Linz, Austria
- Altana Pharma/nycomed
Vienna, Austria
- Altana Pharma/nycomed
Brussels, Belgium
- Altana Pharma/nycomed
Brussels, Belgium
- Altana Pharma/nycomed
Edegern, Belgium
- Altana Pharma/nycomed
Ghent, Belgium
- Altana Pharma/nycomed
Copenhagen NV, Denmark
- Altana Pharma/nycomed
Hvidovre, Denmark
- Altana Pharma/nycomed
Kolding, Denmark
- Altana Pharma/nycomed
Tallinn, Estonia
- Altana Pharma/nycomed
Tartu, Estonia
- Altana Pharma/nycomed
Jyväskylä, Finland
- Altana Pharma/nycomed
Kuopio, Finland
- Altana Pharma/nycomed
Lappeenranta, Finland
- Altana Pharma/nycomed
Oulu, Finland
- Altana Pharma/nycomed
Tampere, Finland
- Altana Pharma/nycomed
Turku, Finland
- Altana Pharma/nycomed
Berlin, Germany
- Altana Pharma/nycomed
Bonn, Germany
- Altana Pharma/nycomed
Dresden, Germany
- Altana Pharma/nycomed
Giessen, Germany
- Altana Pharma/nycomed
Greifswald, Germany
- Altana Pharma/nycomed
Hanover, Germany
- Altana Pharma/nycomed
Hofheim, Germany
- Altana Pharma/nycomed
Konstanz, Germany
- Altana Pharma/nycomed
Lübeck, Germany
- Altana Pharma/nycomed
München, Germany
- Altana Pharma/nycomed
Regensburg, Germany
Site investigator names are published by ClinicalTrials.gov only while a study recruits, so completed studies list sites without them.
Drugs studied
No drug or biological interventions are in our data for this study — it may test a procedure, device or behavioral intervention, or the intervention list isn't in our current snapshot. See the registry record ↗. Why? →
Registration & key dates
Registry attributes as recorded on the ClinicalTrials.gov study record.
- Start
- 30 Nov 2003
- Primary completion
- 31 Mar 2008
- Completion
- 30 Jun 2008
- Last update posted
- 7 May 2012
- Registered enrollment
- 1,200
- Registry id
- NCT00074906
Source: ClinicalTrials.gov, via the CTTI AACT database, data as of 12 Jul 2026. Registry facts are shown as registered by the study sponsor; findmyKOL does not interpret them.